Latest News Valneva Races Ahead in Stock Market Even as Vaccine Lags Behind February 18, 2021February 18, 2021 Future Wealth Daily This post was originally published on this site[unable to retrieve full-text content]French biotechnology company Valneva SE is a laggard in the race to develop a coronavirus vaccine, but it’s starting to catch up to peers in the stock market after a 56% jump this year. Related Posts Latest News Stock market news live updates: Stock futures rise as yields pare gains, JNJ vaccine receives authorization March 1, 2021March 1, 2021 Future Wealth Daily Latest News Cam Goodwin, President of HawsGoodwin Wealth, Earns Prestigious CEPA Designation March 1, 2021March 1, 2021 Future Wealth Daily